SCHEMBL6981090

SCHEMBL6981090

CN1CCC(OC(=O)C(O)(c2ccccc2)C2CCCCC2)C1

nearest known ligand 0.98

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.98
CYP1A2 P05177 1/20 0.98
CYP3A4 P08684 2/20 0.87
CYP2D6 P10635 1/20 0.87
CHRM3 P20309 8/20 0.61
CHRM2 P08172 3/20 0.61
CHRM1 P11229 3/20 0.60
CHRM4 P08173 2/20 0.60
CHRM5 P08912 2/20 0.60
HRH1 P35367 2/20 0.60
KCNH2 Q12809 2/20 0.60
HTR2B P41595 1/20 0.60
HTT P42858 1/20 0.54
SLC29A1 Q99808 1/20 0.53
LMNA P02545 1/20 0.52
KEAP1 Q14145 1/20 0.51
NFE2L2 Q16236 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5385056 1.00 ALDH1A1 (0.98) ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3
SCHEMBL5388335 1.00 ALDH1A1 (0.98) ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3
SCHEMBL5385053 1.00 ALDH1A1 (0.98) ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3
SCHEMBL5388340 1.00 ALDH1A1 (0.98) ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3
SCHEMBL10098821 0.99 ALDH1A1 (1.00) ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3
SCHEMBL1697179 0.99 ALDH1A1 (1.00) ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3
SCHEMBL5391762 0.99 ALDH1A1 (1.00) ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3
SCHEMBL5391765 0.99 ALDH1A1 (1.00) ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3
SCHEMBL5395653 0.99 ALDH1A1 (1.00) ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3
SCHEMBL418425 0.99 ALDH1A1 (1.00) ALDH1A1CYP1A2CYP3A4CYP2D6CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7253182-B2 Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments SOFOTEC GMBH & CO. KG (DE) 2007-08-07 US disclosed
EP-1369414-A1 Enantiomerically pure Arylcycloalkyl hydroxycarboxylic esters, processes for their preparation and their use as modulators of muscarinic receptors Noe, Christian R. (AT) 2003-12-10 EP disclosed
EP-0937041-B1 Use of a pharmaceutically acceptable salt of (3R,2'R)-3-[(Cyclopently-hydroxyphenylacetyl)oxy]-1,1-dimethyl-pyrrolidinium for the preparation of a medicament NOE CHRISTIAN R (DE) 2003-04-23 EP disclosed
EP-0937041-A1 PURE ENANTIOMER BASIC ARYL-CYCLOALKYL-HYDROXYCARBOXYLIC ACID ESTERS, PROCESS FOR PREPARING THE SAME AND THEIR USE IN MEDICAMENTS Noe, Christian R. (DE) 1999-08-25 EP disclosed
WO-1998021183-A1 PURE ENANTIOMER BASIC ARYL-CYCLOALKYL-HYDROXYCARBOXYLIC ACID ESTERS, PROCESS FOR PREPARING THE SAME AND THEIR USE IN MEDICAMENTS NOE CHRISTIAN R (AT) 1998-05-22 WO disclosed